Ketoacidosis, urosepsis, pyelonephritis, acute kidney injury, anaphylaxis, and angioedema appeared as additional adverse effects of canagliflozin and empagliflozin use [42,43,44]
Evaluating glycemic control efficacy and safety of the oral small molecule glucagon-like peptide 1 receptor agonist danuglipron in type 2 diabetes patients: a systemic review and meta-analysis
The process of ordering the pen is made very simple by the staff at the facility
previously reported the treatment of glp-1(bn18) mutants from L4/young adult stages with HU did not induce a Glp phenotype
The RR for achieving the primary outcome in the liraglutide group compared with the placebo was 4.7 (95% CI, 0.375.0
This further indicates that the unusual stability of sll0067 can be due to the attractive charge-charge interactions present in the protein